Guillaume Pfefer, CEO of Sail, explains how the company’s platform is unlocking fully programmable medicines and shares more on two recently announced partnered programs targeting malaria and cystic fibrosis.

About Flagship Pioneering:
Flagship Pioneering is a biotechnology company that invents and builds platform companies, each with the potential for multiple products that transform human health or sustainability. Since its launch in 2000, Flagship has originated and fostered more than 100 scientific ventures. The current Flagship ecosystem comprises 40 companies, including Denali Therapeutics, Foghorn Therapeutics, Generate:Biomedicines, Inari, Indigo Agriculture, Moderna , Omega Therapeutics, Sana Biotechnology, Seres Therapeutics, and Tessera Therapeutics.

Website: www.flagshipioneering.com
Linkedin: www.linkedin.com/company/flagship-pioneering
Twitter: @FlagshipPioneer

свернуть